Search results

Page results

• Loss of smell a ‘highly specific’ indicator of Covid-19, finds UCLH and UCL research

  Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.

• Sarah, Duchess of York and Their Royal Highnesses Princesses Beatrice and Eugenie meet young people with cancer at UCLH

  In a joint public appearance, the trio, who are Honorary Patrons of Teenage Cancer Trust, visited the ward to meet young patients and thank staff for their work.

• Age no criterion for decisions on heart attack treatment, new research finds

  Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.

• Peer review shines spotlight on collaborative excellence and challenges at the Red Cell Network HCC

  Every five years, a national Peer Review process casts a supportive but critical eye over red cell services across the UK.

• Flow-diverting stents (in the treatment of intracranial aneurysms)

  The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.

• Single-dose radiotherapy as effective for treating breast cancer, long-term study finds

  A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.

• SUMMIT Study catches up with pre-pandemic follow up appointments

  As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.

• National play toolkit to reduce children’s medical trauma launched at UCLH

  A new toolkit to support babies, children and young people in healthcare access high quality health play services was launched at UCLH last week with UCLH chief nurse Vanessa Sweeney welcoming visitors from NHS England and the play charity Starlight.

• What is acute myeloid leukaemia (AML)?

  Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.

• Treating acute myeloid leukaemia (AML)

  Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.